Abstract
Computer-based analysis revealed that natural products exhibit a remarkable structural diversity of molecular frameworks and scaffolds that could be systematically exploited for combinatorial synthesis. Natural products offer a rich pool of unique molecular frameworks that complement “drug space”. They possess desirable druglike properties rendering them ideal starting points for molecular design considerations. This review provides an overview of chemotype diversity and molecular properties of collections of drugs and druglike molecules, pure natural products, and natural productderived compounds. Compared to druglike molecules, pure natural products contain more oxygen atoms and chiral centers, and have less aromatic atoms on average. Among the natural product library we identified more than one thousand scaffolds that were not contained in any other compound set analyzed. This outcome provides a basis for the design of new natural product-derived compound libraries. Our study demonstrates that computational chemical biology can assist in finding suitable molecular entities in collections of natural products for drug discovery.
Keywords: Natural products, drug discovery, combinatorial chemistry, library design, virtual screening
Current Chemical Biology
Title: Properties and Architecture of Drugs and Natural Products Revisited
Volume: 1 Issue: 1
Author(s): Kristina Grabowski and Gisbert Schneider
Affiliation:
Keywords: Natural products, drug discovery, combinatorial chemistry, library design, virtual screening
Abstract: Computer-based analysis revealed that natural products exhibit a remarkable structural diversity of molecular frameworks and scaffolds that could be systematically exploited for combinatorial synthesis. Natural products offer a rich pool of unique molecular frameworks that complement “drug space”. They possess desirable druglike properties rendering them ideal starting points for molecular design considerations. This review provides an overview of chemotype diversity and molecular properties of collections of drugs and druglike molecules, pure natural products, and natural productderived compounds. Compared to druglike molecules, pure natural products contain more oxygen atoms and chiral centers, and have less aromatic atoms on average. Among the natural product library we identified more than one thousand scaffolds that were not contained in any other compound set analyzed. This outcome provides a basis for the design of new natural product-derived compound libraries. Our study demonstrates that computational chemical biology can assist in finding suitable molecular entities in collections of natural products for drug discovery.
Export Options
About this article
Cite this article as:
Grabowski Kristina and Schneider Gisbert, Properties and Architecture of Drugs and Natural Products Revisited, Current Chemical Biology 2007; 1 (1) . https://dx.doi.org/10.2174/2212796810701010115
DOI https://dx.doi.org/10.2174/2212796810701010115 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anaphylaxis in Risky Populations
Current Pharmaceutical Design Clinical Aspects of Melatonin in the Acute Coronary Syndrome
Current Vascular Pharmacology Recent Highlights in the Synthesis of Anti-HCV Ribonucleosides
Current Medicinal Chemistry Molecular Pathways of Endothelial Cell Activation for (Targeted) Pharmacological Intervention of Chronic Inflammatory Diseases
Current Vascular Pharmacology Structure-Activity Relationship Study of a Series of N-Substituted Piperazinyl-Fluoroquinolones as Anti-Helicobacter pylori Agents
Medicinal Chemistry Safety Profile of Molnupiravir with Significant Effect on COVID-19: A Review
Current Drug Therapy The Potentials of Uncariae Ramulus Cum Uncis for the Treatment of Migraine: Targeting CGRP in the Trigeminovascular System
Current Neuropharmacology Recent Developments of Small Molecule PI3K/mTOR Dual Inhibitors
Mini-Reviews in Medicinal Chemistry Detection of COVID-19 Incidentally in <sup>68</sup>Ga-PSMA PET/CT for Restaging of Prostate Cancer
Current Medical Imaging Further Exploration of Antimicrobial Ketodihydronicotinic Acid Derivatives by Multiple Parallel Syntheses
Combinatorial Chemistry & High Throughput Screening Green Tea Polyphenols as an Anti-Oxidant and Anti-Inflammatory Agent for Cardiovascular Protection
Cardiovascular & Hematological Disorders-Drug Targets Carbon Monoxide and the Brain: Time to Rethink the Dogma
Current Pharmaceutical Design Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target
Current Signal Transduction Therapy Tackling COVID-19 Through Ayurveda: A Review on the Herbs of Recommended Indian Remedies
Current Traditional Medicine Computational Studies on the Prion Protein
Current Topics in Medicinal Chemistry Developments in Antiviral Drug Design, Discovery and Development in 2004
Current Drug Targets - Infectious Disorders 21.1 Tesla Magnetic Resonance Imaging Apparatus and Image Interpretation: First Report of a Scientific Advancement
Recent Patents on Medical Imaging Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
Medicinal Chemistry Dual Ligands Targeting Dopamine D2 and Serotonin 5-HT<sub>1A</sub> Receptors as New Antipsychotical or Anti-Parkinsonian Agents
Current Medicinal Chemistry A Meta-Analysis of Safety of Different Regimens of Remdesivir in COVID-19 Patients
Current Drug Safety